PEMGX
Price
$43.44
Change
-$0.15 (-0.34%)
Updated
Sep 20 closing price
RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

PEMGX vs RPMGX

Header iconPEMGX vs RPMGX Comparison
Open Charts PEMGX vs RPMGXBanner chart's image
Principal MidCap A
Price$43.44
Change-$0.15 (-0.34%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PEMGX vs RPMGX Comparison Chart
Loading...
VS
PEMGX vs. RPMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Buy and RPMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. PEMGX (27.7B). RPMGX pays higher dividends than PEMGX: RPMGX (0.05) vs PEMGX (0.00). PEMGX was incepted earlier than RPMGX: PEMGX (19 years) vs RPMGX (32 years). RPMGX is a more actively managed with annual turnover of: 21.70 vs. PEMGX (10.10). PEMGX has a lower initial minimum investment than RPMGX: PEMGX (1000) vs RPMGX (2500). PEMGX annual gain was more profitable for investors over the last year : 30.61 vs. RPMGX (14.65). PEMGX return over 5 years is better than : 45.58 vs. RPMGX (14.51).
PEMGXRPMGXPEMGX / RPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years32 years-
Gain YTD18.3019.026203%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets27.7B31.4B88%
Annual Yield % from dividends0.000.05-
Returns for 1 year30.6114.65209%
Returns for 3 years7.31-13.81-53%
Returns for 5 years45.5814.51314%
Returns for 10 years104.0243.29240%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNLN5.380.10
+1.89%
Greenlane Holdings Inc
ATR155.91-0.99
-0.63%
AptarGroup
CEVA23.18-0.24
-1.02%
CEVA
DEI17.23-0.26
-1.49%
Douglas Emmett
LPTX2.77-0.08
-2.64%
Leap Therapeutics